Introducing EleCare®

EleCare is an amino acid-based formula (AAF), which means that it is made from the tiny building blocks of protein (amino acids), which are not recognised by the body and will not cause allergic reactions in any infants with cow’s milk allergy (CMA).1

EleCare is prescribed for infants with severe CMA and/or multiple food allergies, and other conditions where an AAF is clinically indicated (e.g. short bowel syndrome). EleCare can be started from birth (no need to switch at 6 months).


What are the key benefits of EleCare?

  • Shown to improve symptoms of cow’s milk allergy and gastrointestinal disorders like malabsorption and short bowel syndrome2,3
  • Nutritionally complete to meet the daily needs of infants from birth onwards
  • Contains biosynthetic 2’-FL*, a special carbohydrate that is naturally found in most mothers’ breast milk4
  • Can be prepared quickly and safely by mixing in >70°C water (according to HSE and WHO recommendations)5,6
  • Suitable for Halal and Kosher diets
  • Is recommended by parents and healthcare professionals3,7

9 in 10 parents reported that EleCare resolved their infant’s symptoms of food allergy fast†3


Useful resources

02-1-products-alimentum-desktop-faq-alimentum green

Have a question about EleCare?

The answer might be in our FAQs

Browse our FAQs
02-1-products-alimentum-desktop-recipe-book-alimentum green

EleCare recipes

EleCare can also be introduced to your baby as part of a recipe

Download recipes and resources

IMPORTANT NOTICE: Breastfeeding is best for infants and is recommended for as long as possible during infancy. Alimentum and EleCare are infant formulas for special medical purposes and should only be used under the recommendation or guidance of a healthcare professional.

*The 2'-FL (2'-fucosyllactose) used in this formula is biosynthesised and structurally identical to the human milk oligosaccharide (HMO) 2'-FL, found in most mothers' breast milk.4
†Findings from the 2019 EleCare parent survey in infants fed standard EleCare formula without 2’-FL. 168 parents were asked if they agreed with the statement: “EleCare resolved my infant/child’s symptoms fast”. 89% of parents had a response of “strongly agree”, “agree”, and “somewhat agree” (n=150/168).3

FAQs: frequently asked questions; HSE: Health Service Executive; WHO: World Health Organization.

UK-SIMILAC-2000018 November 2020